LIQUID PHARMACEUTICAL COMPOSITION COMPRISING ENSIFENTRINE AND GLYCOPYRROLATE
The present invention relates to a liquid pharmaceutical composition suitable for administration by inhalation comprising: (i) ensifentrine particles; (ii) glycopyrrolate; and (iii) a diluent, which diluent comprises water, wherein: the glycopyrrolate is dissolved in the diluent; the concentration o...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng ; spa |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to a liquid pharmaceutical composition suitable for administration by inhalation comprising: (i) ensifentrine particles; (ii) glycopyrrolate; and (iii) a diluent, which diluent comprises water, wherein: the glycopyrrolate is dissolved in the diluent; the concentration of glycopyrrolate is less than or equal to 5.0 mg/mL; and the pH of the liquid pharmaceutical composition is from 3.0 to 6.0. The invention also relates to a nebuliser comprising the liquid pharmaceutical composition.
La presente invención se refiere a una composición farmacéutica líquida adecuada para administración por inhalación que comprende: (i) partículas de ensifentrina; (ii) glicopirrolato; y (iii) un diluyente, cuyo diluyente comprende agua, en donde: el glicopirrolato se disuelve en el diluyente; la concentración de glicopirrolato es inferior o igual a 5.0 mg/mL; y el pH de la composición farmacéutica líquida es de 3.0 a 6.0. La invención también se refiere a un nebulizador que comprende la composición farmacéutica líquida. |
---|